Engineered Cell‐Penetrating Peptides for Mitochondrion‐Targeted Drug Delivery in Cancer Therapy
Open Access
- 26 August 2021
- journal article
- research article
- Published by Wiley in Chemistry – A European Journal
- Vol. 27 (59) , 14721-14729
Abstract
Mitochondrion is a promising target in cancer therapy. However, gaining access to this organelle is difficult due to the obstacles to cross the complicated mitochondrial membrane. Cell‐penetrating peptides (CPPs) with mitochondrion‐targeting ability, named mitochondrion‐targeting peptides (MTPs), are efficient tools to deliver exogenous therapeutics into mitochondria. Herein, we report several new MTPs, which can be readily synthesized via resin‐based solid‐phase peptide synthesis. In particular, MTP3 (compound 5), consisting of three positively charged arginines and two D‐ and L‐ alternating naphthylalanines, demonstrated excellent mitochondrion‐targeting ability with high Pearson's correlation coefficient, suggesting that MTP3 has good potential for mitochondrion‐targeted drug delivery. As proof‐of‐concept, the feasibility of MTP3 was validated by the preparation of a mitochondrion‐targeting prodrug (compound 17, doxorubicin‐based prodrug). This prodrug was subsequently confirmed to be specifically transported to the mitochondria of tumor cells, where it was able to release the native doxorubicin upon intracellular GSH activation, leading to mitochondrial depolarization and eventually cell death. Importantly, compound 17 showed good cytotoxicity against human tumor cells while negligible toxicity towards normal cells, indicating its potential as a potent mitochondrial medicine for targeted cancer therapy. Our study thus opens a way for engineered CPPs to be used to deliver bioactive cargos in mitochondrion‐targeted cancer therapy.Keywords
Funding Information
- National Natural Science Foundation of China (21877130,U1801681)
- National Research Foundation Singapore (SBP-P4 and SBP-P8)
- Natural Science Foundation of Guangdong Province (2018A030313510 and 2021A1515010357)
This publication has 42 references indexed in Scilit:
- Current Challenges in Cancer TreatmentClinical Therapeutics, 2016
- Recent development of biotin conjugation in biological imaging, sensing, and target deliveryChemical Communications, 2015
- Glutathione and mitochondriaFrontiers in Pharmacology, 2014
- Design, synthesis and biological evaluation of mitochondria targeting theranostic agentsChemical Communications, 2014
- Cell-penetrating peptides: classes, origin, and current landscapeDrug Discovery Today, 2012
- Mitochondria: In Sickness and in HealthCell, 2012
- Mitochondrial Glutathione, a Key Survival AntioxidantAntioxidants & Redox Signaling, 2009
- Mitochondria-Penetrating PeptidesChemistry & Biology, 2008
- Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumoursJournal of Inorganic Biochemistry, 2004
- The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid molecular transportersProceedings of the National Academy of Sciences, 2000